Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 64 Links/Repositories
ID/Name Source Type
[AlzPED] Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind).
18926877 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer’s disease
15778881 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease.
21918687 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model
20847440 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model.
21889983 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation
21387370 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] AVN-211, Novel and Highly Selective 5‑HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer’s Disease
26886442 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models.
27829340 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model
25945128 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository
[AlzPED] Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
16938404 Alzheimer's Disease Preclinical Efficacy Database (AlzPED) Repository